Revagenix, Inc. is a California-based biopharmaceutical company developing anti-infective and antimicrobial medicines. Its lobbying is focused on promoting opportunities for antimicrobial drug development and related medical research and clinical lab issues. Filings show five reports totaling $170,000 and the firm The Conafay Group was hired to represent these interests.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRYAN SHUY
The latest disclosures for this client.
THE CONAFAY GROUP, LLC
Q3THE CONAFAY GROUP, LLC
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE CONAFAY GROUP, LLC
JOSH NARROW
THE CONAFAY GROUP, LLC
mr DARIN L GARDNER
THE CONAFAY GROUP, LLC
THE CONAFAY GROUP, LLC
Q1THE CONAFAY GROUP, LLC
Q4THE CONAFAY GROUP, LLC
Q3THE CONAFAY GROUP, LLC
Q2THE CONAFAY GROUP, LLC
Q1THE CONAFAY GROUP, LLC
RR